SOTIO Biotech AG
SOTIO Biotech AG
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors | DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, hepatocellular carcinoma, liposarcoma, liver disorder, myxoid liposarcoma, myxoid/round cell liposarcoma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, sarcoma, squamous cell lung carcinoma, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-05 | NCT05120271 | |
| A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2025-06-29 | NCT06163391 |